STAT+: Xenon’s seizure drug study reads out soon. Here’s what to expect

Xenon Pharmaceuticals is developing a drug for the most common type of seizures in people with epilepsy. The study of this drug will soon be completed and the results will be published. The drug targets a common type of epileptic seizures.[1]